ArticleMikrochimica acta2019
1-Pyrene carboxylic acid functionalized carbon nanotube-gold nanoparticle nanocomposite for electrochemical sensing of dopamine and uric acid.
Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 22 citations in OpenAlex.
- Pyrene Derivative-Based Electrode for Electrochemical Sensing.Small methods · 2026Article
- Electrochemical Sensing of Dopamine with P-g-CBiosensors · 2026Article
- Electrochemical sensor based on dual-template molecularly imprinted polymer and nanoporous gold leaf modified electrode for simultaneous determination of dopamine and uric acid.Mikrochimica acta · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A highly sensitive, selective and cost effective method is described for sensing dopamine (DA) and uric acid (UA). A glassy carbon electrode (GCE) was modified with a nanocomposite consisting of gold nanoparticle-loaded multi-walled carbon nanotube (CNT) modified with 1-pyrene carboxylic acid (PCA). The stable aqueous dispersion of non-covalently functionalized CNT-PCA is an efficient bioprobe for the ultra sensitive and selective detection of dopamine and uric acid in the presence of the potentially interfering agent ascorbic acid (AA). The presence of PCA on the CNT introduces anionic carboxyl groups which repel ascorbate. The presence of the pyrene group augments high electrocatalytic activity towards oxidation of DA and UA, and the gold nanoparticles contribute to the amplification of the signal. The modified GCE gives an excellent peak current with well distinguishable peaks for AA, DA and UA (near -0.08 V, +0.14 V, and +0.22 V vs Ag/AgCl) in differential pulse voltammetry. Chronoamperometric detection of DA (working potential of 0.16 V vs Ag/AgCl) and UA (working potential of 0.3 V vs Ag/AgCl) showed linear ranges of 1 nM-150 μM (LOD 1 nM) and 1 μM-240 μM (LOD 1 μM) for DA and UA, respectively. The nanoprobe was validated by monitoring the recovery of spiked DA and UA in human blood serum samples which indicated a recovery within ±2%. Graphical abstract A glassy carbon electrode modified with a gold nanoparticle-loaded multi-walled carbon nanotube (CNT) - 1-pyrene carboxylic acid (PCA) composite was used for the sensitive and selective detection of the dopamine and uric acid.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.